Bio-Rad to Participate at the 37th Annual J.P. Morgan Healthcare Conference on January 8
HERCULES, Calif.--(BUSINESS WIRE)--Jan 2, 2019--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO, and Christine Tsingos, Executive Vice President and CFO, will participate in the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, at 1:30 PM (Pacific Time), at the Westin St. Francis Hotel, San Francisco, California.
A link to the live webcast of the presentation will be available in the Investor Relations area of our website at www.bio-rad.com.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied research laboratories that include food safety and environmental quality testing. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with more than 8,000 employees worldwide. Bio-Rad had revenues exceeding $2.1 billion in 2017. For more information, please visit www.bio-rad.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190102005649/en/
CONTACT: Bio-Rad Laboratories, Inc.
Tina Cuccia, Corporate Communications
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY RESEARCH SCIENCE
SOURCE: Bio-Rad Laboratories, Inc.
Copyright Business Wire 2019.
PUB: 01/02/2019 06:10 PM/DISC: 01/02/2019 06:10 PM